Simplex Trading
BCYC

Simplex Trading’s Bicycle Therapeutics BCYC Stock Holding History

Simplex Trading’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,986
Closed -$114K – 9061
2025
Q4 		$142K Buy
+19,986
New +$147K ﹤0.01% 4606
2025
Q3 		– Sell
-1,241
Closed -$9.37K – 9052
2025
Q2 		$8K Buy
1,241
+670
+117% +$5.34K ﹤0.01% 7441
2025
Q1 		$4K Buy
+571
New +$6.73K ﹤0.01% 7635
2024
Q4 		– Sell
-771
Closed -$16.5K – 8504
2024
Q3 		$17K Buy
771
+251
+48% +$5.79K ﹤0.01% 6782
2024
Q2 		$10K Sell
520
-9,310
-95% -$210K ﹤0.01% 7399
2024
Q1 		$244K Buy
+9,830
New +$209K ﹤0.01% 4629
2023
Q4 		– Sell
-31,534
Closed -$522K – 8763
2023
Q3 		$633K Sell
31,534
-34,909
-53% -$798K ﹤0.01% 3151
2023
Q2 		$1.7M Buy
66,443
+40,555
+157% +$942K ﹤0.01% 2108
2023
Q1 		$550K Buy
25,888
+11,554
+81% +$290K ﹤0.01% 3165
2022
Q4 		$424K Buy
14,334
+14,092
+5,823% +$378K ﹤0.01% 3342
2022
Q3 		$5K Buy
+242
New +$5.76K ﹤0.01% 8745
2022
Q1 		– Sell
-1,557
Closed -$72.7K – 10377
2021
Q4 		$94K Buy
+1,557
New +$85.9K ﹤0.01% 6351

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's BCYC Position: Q1 2026 in Review

Simplex Trading sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 19,986 shares — an estimated $114K sold.

Simplex Trading first reported a position in BCYC in Q4 2021 and held it in 12 quarters. The position peaked at $1.7M in Q2 2023. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Simplex Trading reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 19,986 Bicycle Therapeutics shares in Q1 2026, an estimated $114K.
  • Simplex Trading first reported a position in Bicycle Therapeutics in Q4 2021 and held it in 12 quarters.
  • Simplex Trading's Bicycle Therapeutics position peaked at $1.7M in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.